Moorestown, NJ. 22 November 2016. Xerimis announces the debut of its purpose-built, 13,000-square foot United Kingdom facility – the second location for the privately held, New Jersey-headquartered customized clinical packaging provider, formally marking its expansion into international markets.
Located thirty minutes west of Heathrow and within easy access of London, the MHRA-approved space is designed to receive, store, label, package and distribute clinical supplies within the European Union. The facility holds WDA, MIA-IMP, and MS licenses, and is the most recent stride in strategic efforts to establish systems overseas while enhancing those currently provided to Xerimis clients in the United States.
Three on-site QPs at this new location work with clients on QP services ranging from CTA submission to QP releases of finished packaged supplies.